| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| L-Arginine | COVID-19 Infection | 10 | PM | 37239763 | 📋 | The Effects of Arginine-Based Supplements on Fatigue Levels following COVID-19 Infection: A Prospective Study in Romania |
| L-Arginine | COVID-19 Infection | 9 | PM | 37238755 | 📋 | Hydroxytyrosol and Arginine as Antioxidant, Anti-Inflammatory and Immunostimulant Dietary Supplements for COVID-19 and Long COVID |
| L-Arginine | COVID-19 Infection | 7 | PM | 36804278 | 📋 | Beneficial Effects of L-Arginine in Patients Hospitalized for COVID-19: New Insights from a Randomized Clinical Trial |
| L-Arginine | COVID-19 Infection | 6 | PM | 36722278 | 📋 | Inhibition of SARS-CoV-2 Mpro with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination |
| L-Arginine | COVID-19 Infection | 4 | PM | 35868478 | 📋 | Combining L-Arginine with Vitamin C Improves Long-COVID Symptoms: The Nationwide Multicenter LINCOLN Study |
| L-Arginine | COVID-19 Infection | 3 | PM | 35323682 | 📋 | Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy |
| L-Arginine | COVID-19 Infection | 2 | PM | 35052325 | 📋 | Clinical Study on the Efficacy and Safety of Arginine Administered Orally in Association with Other Active Ingredients for the Prevention and Treatment of Sarcopenia in Patients with COVID-19-Related Pneumonia, Hospitalized in a Sub-Intensive Care Unit |
| L-Arginine | COVID-19 Infection | 1 | PM | 34522871 | 📋 | Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis |
| L-Arginine | Herpes Simplex Infection | 1 | PM | 19288025 | 📋 | Antiviral Effect of Arginine Against Herpes Simplex Virus Type 1 |
| L-Arginine | HIV/AIDS | 1 | PM | 10850936 | 📋 | Nutritional Treatment for Acquired Immunodeficiency Virus-Associated Wasting Using Beta-Hydroxy Beta-Methylbutyrate, Glutamine, and Arginine: A Randomized, Double-Blind, Placebo-Controlled Study |
| L-Arginine | Human T-Cell Lymphotropic Virus | 1 | PM | 36547017 | 📋 | Efficacy of l-Arginine treatment in patients with HTLV-1-associated neurological disease |
